Studies on homocysteine and dehydroepiandrosterone sulphate plasma levels in alzheimer's disease patients and in Parkinson's disease patients

S. Genedani, G. Rasio, P. Cortelli, F. Antonelli, D. Guidolin, M. Galantucci, K. Fuxe, Luigi F. Agnati

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Homocysteine (HC) and dehydroepiandrosterone sulphate (DHEAS) plasma levels have been evaluated in groups of male and female patients with Parkinson's Disease (PD) and in a group of female patients with Alzheimer's Disease (AD) and compared with the corresponding plasma levels observed in a group of age-matched subjects. It has been confirmed that HC plasma levels are enhanced in both PD and AD patients. As far as the DHEAS plasma levels are concerned no changes have been observed in PD patients while a marked decrease has been observed in AD patients. These results support the view that while the pro-oxidant effects of HC and its agonist action at NMDA receptors can play a role in both neu-rodegenerative diseases, the role of DHEAS is more complex and may be an important factor only in certain neurodegenerative diseases. Thus, according to the present study DHEAS is likely to be involved in AD but not in PD.

Original languageEnglish
Pages (from-to)327-332
Number of pages6
JournalNeurotoxicity Research
Volume6
Issue number4
DOIs
Publication statusPublished - 2004

Fingerprint

Dehydroepiandrosterone Sulfate
Homocysteine
Parkinson Disease
Alzheimer Disease
Plasmas
N-Methyl-D-Aspartate Receptors
Neurodegenerative Diseases
Reactive Oxygen Species
Research Design
Neurodegenerative diseases
Age Groups

Keywords

  • Alzheimer's disease
  • Dehydroepiandrosterone sulphate
  • Homocysteine
  • Human patients
  • Parkinson's disease

ASJC Scopus subject areas

  • Neuroscience(all)
  • Toxicology

Cite this

Studies on homocysteine and dehydroepiandrosterone sulphate plasma levels in alzheimer's disease patients and in Parkinson's disease patients. / Genedani, S.; Rasio, G.; Cortelli, P.; Antonelli, F.; Guidolin, D.; Galantucci, M.; Fuxe, K.; Agnati, Luigi F.

In: Neurotoxicity Research, Vol. 6, No. 4, 2004, p. 327-332.

Research output: Contribution to journalArticle

Genedani, S. ; Rasio, G. ; Cortelli, P. ; Antonelli, F. ; Guidolin, D. ; Galantucci, M. ; Fuxe, K. ; Agnati, Luigi F. / Studies on homocysteine and dehydroepiandrosterone sulphate plasma levels in alzheimer's disease patients and in Parkinson's disease patients. In: Neurotoxicity Research. 2004 ; Vol. 6, No. 4. pp. 327-332.
@article{22fac6de7b5c42b3ace10d51dc19eaa8,
title = "Studies on homocysteine and dehydroepiandrosterone sulphate plasma levels in alzheimer's disease patients and in Parkinson's disease patients",
abstract = "Homocysteine (HC) and dehydroepiandrosterone sulphate (DHEAS) plasma levels have been evaluated in groups of male and female patients with Parkinson's Disease (PD) and in a group of female patients with Alzheimer's Disease (AD) and compared with the corresponding plasma levels observed in a group of age-matched subjects. It has been confirmed that HC plasma levels are enhanced in both PD and AD patients. As far as the DHEAS plasma levels are concerned no changes have been observed in PD patients while a marked decrease has been observed in AD patients. These results support the view that while the pro-oxidant effects of HC and its agonist action at NMDA receptors can play a role in both neu-rodegenerative diseases, the role of DHEAS is more complex and may be an important factor only in certain neurodegenerative diseases. Thus, according to the present study DHEAS is likely to be involved in AD but not in PD.",
keywords = "Alzheimer's disease, Dehydroepiandrosterone sulphate, Homocysteine, Human patients, Parkinson's disease",
author = "S. Genedani and G. Rasio and P. Cortelli and F. Antonelli and D. Guidolin and M. Galantucci and K. Fuxe and Agnati, {Luigi F.}",
year = "2004",
doi = "10.1007/BF03033443",
language = "English",
volume = "6",
pages = "327--332",
journal = "Neurotoxicity Research",
issn = "1029-8428",
publisher = "Springer New York",
number = "4",

}

TY - JOUR

T1 - Studies on homocysteine and dehydroepiandrosterone sulphate plasma levels in alzheimer's disease patients and in Parkinson's disease patients

AU - Genedani, S.

AU - Rasio, G.

AU - Cortelli, P.

AU - Antonelli, F.

AU - Guidolin, D.

AU - Galantucci, M.

AU - Fuxe, K.

AU - Agnati, Luigi F.

PY - 2004

Y1 - 2004

N2 - Homocysteine (HC) and dehydroepiandrosterone sulphate (DHEAS) plasma levels have been evaluated in groups of male and female patients with Parkinson's Disease (PD) and in a group of female patients with Alzheimer's Disease (AD) and compared with the corresponding plasma levels observed in a group of age-matched subjects. It has been confirmed that HC plasma levels are enhanced in both PD and AD patients. As far as the DHEAS plasma levels are concerned no changes have been observed in PD patients while a marked decrease has been observed in AD patients. These results support the view that while the pro-oxidant effects of HC and its agonist action at NMDA receptors can play a role in both neu-rodegenerative diseases, the role of DHEAS is more complex and may be an important factor only in certain neurodegenerative diseases. Thus, according to the present study DHEAS is likely to be involved in AD but not in PD.

AB - Homocysteine (HC) and dehydroepiandrosterone sulphate (DHEAS) plasma levels have been evaluated in groups of male and female patients with Parkinson's Disease (PD) and in a group of female patients with Alzheimer's Disease (AD) and compared with the corresponding plasma levels observed in a group of age-matched subjects. It has been confirmed that HC plasma levels are enhanced in both PD and AD patients. As far as the DHEAS plasma levels are concerned no changes have been observed in PD patients while a marked decrease has been observed in AD patients. These results support the view that while the pro-oxidant effects of HC and its agonist action at NMDA receptors can play a role in both neu-rodegenerative diseases, the role of DHEAS is more complex and may be an important factor only in certain neurodegenerative diseases. Thus, according to the present study DHEAS is likely to be involved in AD but not in PD.

KW - Alzheimer's disease

KW - Dehydroepiandrosterone sulphate

KW - Homocysteine

KW - Human patients

KW - Parkinson's disease

UR - http://www.scopus.com/inward/record.url?scp=21644471827&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=21644471827&partnerID=8YFLogxK

U2 - 10.1007/BF03033443

DO - 10.1007/BF03033443

M3 - Article

C2 - 15545016

AN - SCOPUS:21644471827

VL - 6

SP - 327

EP - 332

JO - Neurotoxicity Research

JF - Neurotoxicity Research

SN - 1029-8428

IS - 4

ER -